Indivior Pharmaceuticals, Inc. — Balance Sheet Charts
9 snapshots of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↓-12.9% -$178M
$1.20B
Current Assets↓-24.5% -$216M
$667M
Cash & Equivalents↓-53.0% -$197M
$175M
ST Investments↓-100.0% -$1M
$0
Receivables↑+12.3% +$30M
$273M
Inventory↓-6.7% -$11M
$152M
Net PPE↑+51.0% +$53M
$157M
Goodwill↑+0.0% +$0
$2M
Total Liabilities↓-19.2% -$319M
$1.34B
Current Liabilities↓-22.5% -$226M
$779M
Account Payables↓-23.9% -$11M
$35M
Long-Term Debt↑+56.3% +$175M
$486M
Stockholders Equity↑+49.5% +$141M
$-144M
Retained Earnings↑+31.0% +$126M
$-280M
Operating Lease ROU Asset↓-40.5% -$15M
$22M
Operating Lease Liability↓-53.3% -$16M
$14M
Gross PP&E↑+36.0% +$71M
$268M
Accumulated Depreciation↑+20.7% +$19M
$111M
Inventory WIP↑+51.3% +$20M
$59M
Inventory Finished Goods↓-33.7% -$35M
$69M
Debt Due Y1↑+11.3% +$6M
$59M
Debt Due Y2↑+7.8% +$4M
$55M
Debt Due Y3↓-8.8% -$5M
$52M
Debt Due Y4↓-9.1% -$5M
$50M
Debt Due Y5↑+367.3% +$191M
$243M
Debt Due >Y5↓-100.0% -$256M
$0